▟ Vinebot intrinsic value, daily

← back

NDAQ Nasdaq, Inc.

exchanges · valued with opus medium conviction · deep-dived 2026-11-20

BUY
Intrinsic value$72.69
Price (at call)$103.95
Margin of safety -30.1%
vs market (rating basis) +14.8%

A good exchange-plus-software franchise, but $104 already assumes margins and growth above durable economics.

The story

Nasdaq has become a hybrid: a cash-equities and options exchange plus a recurring-revenue fintech and data/index business (Adenza, Verafin, index licensing) that now drives most of its profit. Network effects in listings and index brands, plus high switching costs in regulatory and risk software, make for a durable but maturing moat. Growth will come mostly from cross-selling software and selling more index and data subscriptions, not from expanding trading volumes. The Adenza acquisition left it with a heavy goodwill base and about $8.4B of net debt.

Most drivers stay where they were. TTM revenue grew about 11% and margin reached 32.1%, which is consistent with the path to 36%, so I nudged year-1 growth up only slightly, from 8% to 8.5%. Revenue here is gross of transaction rebates, so 36% on this base is already a rich margin, and I won't push it higher. The reported 0.43 sales-to-capital is depressed by Adenza goodwill; incremental software and data growth is capital-light, so I keep 2.0.

Value drivers

Revenue growth (Y1)8.5%
Terminal growth3.5%
Forecast horizon10y
Target operating margin36.0%
Years to target margin5
Sales-to-capital2.00
Beta0.95
Failure probability1.0%
Cost of capital (WACC)8.9%
Terminal WACC9.1%

Valuation bridge

PV of explicit FCFF21.92B
PV of terminal value27.24B
Equity value40.34B
÷ shares → per share$72.69

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 9.97B 8.5% 32.9% 2.73B 390.40M 2.34B 2.15B
2 10.76B 7.9% 33.6% 3.02B 395.90M 2.62B 2.21B
3 11.55B 7.4% 34.4% 3.31B 397.47M 2.92B 2.26B
4 12.34B 6.8% 35.2% 3.62B 394.75M 3.23B 2.30B
5 13.12B 6.3% 36.0% 3.93B 387.43M 3.55B 2.32B
6 13.87B 5.7% 36.0% 4.16B 375.32M 3.78B 2.27B
7 14.59B 5.2% 36.0% 4.37B 358.27M 4.02B 2.21B
8 15.26B 4.6% 36.0% 4.58B 336.27M 4.24B 2.15B
9 15.88B 4.1% 36.0% 4.76B 309.39M 4.45B 2.07B
10 16.43B 3.5% 36.0% 4.93B 277.84M 4.65B 1.99B

Key risks

  • Fintech growth slows (Adenza cross-sell, Verafin adoption) and the software multiple compresses
  • Rebate and fee pressure in equities and options, or regulatory changes to market structure
  • Leverage from the Adenza deal limits flexibility if trading volumes fall in a downturn

Catalysts

  • Steady double-digit growth in Adenza and Verafin annual recurring revenue (ARR) plus visible cross-sell wins
  • Debt paydown back to target leverage, freeing cash for buybacks

History

DatePriceIntrinsicMoSRating
2026-11-20$103.95 $72.69 -30.1% BUY
2026-11-09$107.12 $73.20 -31.7% BUY
2026-10-27$104.72 $71.44 -31.8% BUY
2026-10-14$93.48 $57.47 -38.5% BUY
2026-10-01$92.01 $56.67 -38.4% BUY
2026-09-18$91.31 $49.00 -46.3% BUY
2026-09-07$96.88 $50.82 -47.5% BUY
2026-08-25$98.79 $51.87 -47.5% BUY
2026-08-12$95.02 $50.66 -46.7% BUY
2026-07-30$95.55 $51.47 -46.1% BUY
2026-07-16$91.36 $48.43 -47.0% HOLD
2026-07-03$84.66 $51.23 -39.5% BUY
2026-06-23$82.49 $49.70 -39.7% BUY